ワクチンアジュバントの世界市場：粒子状アジュバント、アジュバント・エマルション、病原体、サポニン、組合せアジュバント...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Markets Covered
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Key Indicators
2.1.1 Introduction
2.1.2 Macroindicators
2.1.2.1 Rapid Growth of Aging Population
2.1.2.2 Incidence and Prevalence of Cancer
2.1.2.3 Burden of Infectious Diseases
2.1.2.4 Healthcare Expenditure Patterns
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Key Data From Secondary Sources
2.5 Key Data From Primary Sources
2.6 Key Industry Insights
2.7 Assumptions for the Study

3 Executive Summary (Page No. – 32)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 38)
4.1 Market Overview
4.2 Market, By Application
4.3 Geographical Snapshot of the Market
4.4 Geographic Analysis: Market, By Application Category
4.5 Geographic Analysis: Market, By Disease Type
4.6 Lifecycle Analysis, By Region, 2015

5 Market Overview (Page No. – 44)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Use of Adjuvants in Vaccine
5.2.1.2 High Prevalence of Infectious and Zoonotic Diseases
5.2.1.3 Increase in Livestock and Instances of Diseases
5.2.1.4 Increasing Focus on Immunization Programs From Various Government Bodies
5.2.1.5 Technological Advancements in Aluminum Hydroxide-Based Adjuvants
5.2.1.6 Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants
5.2.1.7 Increasing Geriatric Population
5.2.2 Restraints
5.2.2.1 High Cost of Adjuvant Research
5.2.2.2 Stringent Regulatory Environment and Time-Consuming Approvals
5.2.3 Opportunities
5.2.3.1 Combination Adjuvants
5.2.3.2 Pandemic Diseases
5.2.4 Challenges
5.2.4.1 Identification of Adjuvants
5.2.5 Trends
5.2.5.1 Collaborations
5.3 Key Pipeline Products
5.4 Regulatory Landscape
5.4.1 North America
5.4.2 Europe
5.4.2.1 Manufacturing Specifications
5.4.2.2 Routine Testing
5.4.2.3 Stability
5.4.3 Asia
5.4.4 RoW

6 Global Vaccine Adjuvants Market, By Product Type (Page No. – 58)
6.1 Introduction
6.2 Particulate Adjuvants
6.3 Adjuvant Emulsions
6.4 Pathogen Components
6.5 Combination Adjuvants
6.6 Others

7 Global Vaccine Adjuvants Market, By Route of Administration (Page No. – 72)
7.1 Introduction
7.2 Intramuscular Route
7.3 Subcutaneous Route
7.4 Intranasal Route
7.5 Oral Route
7.6 Intradermal Route
7.7 Others

8 Global Vaccine Adjuvant Market, By Disease Type (Page No. – 81)
8.1 Introduction
8.2 Infectious Diseases
8.3 Cancer
8.4 Others

9 Global Vaccine Adjuvants Market, By Application (Page No. – 88)
9.1 Introduction
9.2 Research Application
9.3 Commercial Application

10 Global Vaccine Adjuvants Market, By Application Category (Page No. – 93)
10.1 Introduction
10.2 Human Vaccine Adjuvants
10.3 Veterinary Vaccine Adjuvants

11 Global Vaccine Adjuvants Market, By Region (Page No. – 98)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia
11.4.1 China
11.4.2 India
11.4.3 Rest of Asia
11.5 Rest of the World

12 Competitive Landscape (Page No. – 125)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Agreements & Collaborations
12.3.2 Acquisitions
12.3.3 Expansions
12.3.4 Others

13 Company Profile (Page No. – 130)
(Overview, Financial*, Products & Services, Strategy, and Developments)
13.1 Introduction
13.2 Brenntag Biosector A/S (A Subsidiary of Brenntag AG)
13.3 Seppic (A Subsidiary of Air Liquide Group)
13.4 CSL Limited
13.5 Agenus, Inc.
13.6 Novavax, Inc.
13.7 Invivogen
13.8 SPI Pharma, Inc. (A Subsidiary of Associated British Foods PLC.)
13.9 Avanti Polar Lipids, Inc.
13.10 MPV Technologies, Inc.
13.11 OZ Biosciences

*Details Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 148)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Available Customizations
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Related Reports